New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
06:01 EDTACORAcorda Therapeutics downgraded to Neutral from Buy at Citigroup
Citigroup downgraded Acorda Therapeutics citing a lack of near-term catalysts and lowered its price target for shares to $33 from $37.
News For ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
08:31 EDTACORAcorda Therapeutics management to meet with Leerink
Subscribe for More Information
06:31 EDTACORAcorda Therapeutics reports Q3 AMPYRA net sales $105.5M vs. $87.4M a year ago
06:29 EDTACORAcorda Therapeutics narrows FY15 Ampyra net sales view to $410M-$420M
Subscribe for More Information
06:27 EDTACORAcorda Therapeutics reports Q2 non-GAAP EPS 31c, consensus 17c
Subscribe for More Information
July 22, 2015
07:05 EDTACORAcorda Therapeutics awarded grant to study ACRUS technology in RDS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use